• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Life Science Partners

Forecast fundraising closes
LSP closes LSP 7 at EUR 1bn

The GP says it is the largest life sciences venture capital fund ever raised in Europe

  • Funds
  • 14 February 2022
Company management teams and non-executive directors
EQT acquires LSP, forming EQT Life Sciences

Announcement follows Life Sciences Partners' seven-month, EUR 850m fundraise for LSP VII

  • GPs
  • 10 November 2021
Coronary medicine
Forbion et al. in $196m round for NewAmsterdam Pharma

Company intends to use the fresh capital to finance the full phase-III development of its obicetrapib drug

  • Early-stage
  • 15 January 2021
MedPharm is a contract drug developer
Life Science Partners et. al in series-A round for Vico Therapeutics

Biotech startup will use the proceeds to further advance its therapy

  • Early-stage
  • 30 July 2020
Science laboratories and medical diagnostics
LSP invests €5m in Kiadis Pharma

Company is listed on the regulated market of Euronext Amsterdam and Euronext Brussels

  • PIPEs
  • 04 May 2020
Dollar-denominated life sciences fund
LSP closes sixth fund on $600m

Fund invests in European companies developing new medications and medical technologies

  • Funds
  • 10 March 2020
Coronary medicine
LSP leads €10.5m series-D for Xeltis

Life Sciences Partners first invested in the medical devices company in 2014

  • Early-stage
  • 09 September 2019
Biotechnology and medical sciences
LSP, Andera et al. invest €116m in AM-Pharma

Forbion, Ysios Capital and Idinvest also back the financing for the biopharmaceutical company

  • Expansion
  • 16 July 2019
Pharma-focused fundraises
HTGF-backed Immunic lists on Nasdaq

Consortium including LSP, Bayern Kapital, HTGF and IBG reinvested €26.7m in Immunic

  • PIPEs
  • 15 April 2019
Microscopes and laboratory equipment
LSP in $50m series-A for Snipr Biome

Lundbeckfonden Emerge invested an undisclosed sum in an exploratory investment in 2017

  • Early-stage
  • 12 March 2019
The Netherlands
Benelux venture fundraising outpaces buyout counterpart

Last year’s €887m committed to venture funds is the second highest ever seen in the region, after 2016’s record of €1.03bn

  • Fundraising
  • 18 January 2019
Atlantic Therapeutics makes incontinence therapy products
LSP leads €28m series-B for Atlantic Therapeutics

Andera Partners, Atlantic Bridge, Seroba and Earlybird also take part in the round

  • Expansion
  • 08 January 2019
Medical software
LSP leads $28m round for Lumeon

Healthcare software company will expand its US operations and invest in marketing

  • Expansion
  • 05 December 2018
Pharma-focused fundraises
LSP raises €410m for sixth flagship fund

Netherlands-based life sciences specialist has raised €750m across three funds in 10 months

  • Funds
  • 13 November 2018
Computer animation of DNA strand
Andera and LSP lead $84m series-B for Artios

Biotech firm will undertake clinical proof-of-concept trials for its DNA polymerase theta programme

  • Early-stage
  • 10 August 2018
Life sciences vehicle announces fund close
LSP closes €280m healthcare fund

Fund is the largest in Europe dedicated purely to medical technology investments

  • Funds
  • 12 December 2017
Vaccines and injections
VC firms in $59.6m series-C for Hookipa

New investors include HB Partners, Hillhouse Capital, Sirona Capital and Gilead Sciences

  • Early-stage
  • 12 December 2017
Coronary medicine
Ysios Capital backs €45m series-C for Xeltis

Life Sciences Partners, Kurma Partners and VI Partners also took part in the round

  • Early-stage
  • 16 November 2017
Treatments for cancer
LSP in €42m series-B for Nouscom

Abingworth leads the round with participation from 5am Ventures and Versant Ventures

  • Early-stage
  • 06 November 2017
Clinical trials and biotechnology
Life Sciences Partners leads €31.7m series-A for Immunic

LSP led the round, which initially closed on €17.5m in 2016, with Omega and Fund+ joining

  • Early-stage
  • 07 September 2017
Coronary medicine
LSP leads €15m series-A for Cardior Pharmaceuticals

New funding will allow the company to develop its lead compound, which targets RNAs linked to heart failure

  • Early-stage
  • 12 May 2017
Laboratory equipment and furnishings
EMBL and Life Sciences Partners sell Luxendo to Bruker

Bruker will expand its portfolio with the addition of Luxendo's microscopes and intellectual property

  • Exits
  • 09 May 2017
Biotechnology and medical sciences
BIVF at al. lead €20m series-A for ImCheck Therapeutics

Backers include Kurma Partners, Idinvest, Gimv and Life Sciences Partners

  • Early-stage
  • 03 May 2017
Histology and medical imaging technology
EMBL, Life Sciences Partners lead €8m series-A for Luxendo

GPs completed the funding round launched in 2015 with an additional €2m injection

  • Early-stage
  • 12 January 2017
1 2 3
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013